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selected for the development of mapping algorithms. The linear regression model 
had best model fit. However, the SEM that incorporated item level data for ordinal 
responses to each instrument showed better predictive performance, especially at 
the lower end of the EQ-5D distribution. ConClusions: This study demonstrates 
the flexibility of SEMs for the development of mapping algorithms. The models 
developed showed comparable predictive performance to existing models in the 
published literature.
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objeCtives: Network Meta-Analysis (NMA) is becoming a key component of sub-
missions to reimbursement agencies world-wide, especially when there is limited 
head-to-head evidence for multiple technologies. However, almost all NMAs only 
consider Randomised Controlled Trials (RCTs) even though there may be consid-
erable Real World Evidence (RWE) available – for example observational studies 
or registry-based studies. Evaluation of methods to enable the inclusion of RWE, 
especially in the light of the changing nature of RCTs from both a regulatory and 
reimbursement perspective, is considered here. Methods: RCTs and RWE stud-
ies were searched for using standard filters and databases up to, and including, 
the regulatory approval of Fingolimod by the European Medicines Agency (EMA) in 
2011 for Multiple Sclerosis (MS). A number of NMAs were then conducted and which 
included; only RCTs, both RCTs and RWE (accepted at face-value), both RCTs and 
RWE but including an additional level in the NMA hierarchical model to represent 
the different study designs, and finally both RCTs and RWE but adjusting the RWE 
for potential biases. Results: Identification of RWE in addition to RCTs in this 
MS example significantly increased the number of studies (and comparisons) that 
were potentially included in the NMA. Whilst the inclusion of the additional RWE 
led to a reduction in the level of uncertainty surrounding most effect estimates, 
this depended on the method of inclusion adopted for the RWE, and the extent to 
which biases were adjusted for. ConClusions: This initial evaluation of methods 
for the inclusion of RWE in NMAs indicates that methods of adjustment for the 
potential biases in RWE can have a significant impact on the level of uncertainty. 
Consequently further work investigating both empirical evidence for such biases 
and methods of elicitation from experts on the extent of biases associated with 
individual RWE studies is warranted.
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objeCtives: In meta-analysis, model selection is an important criterion which 
needs to be tested and validated by strong statistical evidence. The Cohran’s Q-test 
allows in theory to decide between random-effect and fixed-effect models. Due 
to the highly conservative nature of this test, three statistics have been built to 
estimate the heterogeneity between studies to lead the model decision: the I2, the 
H2 and the R2. We conducted a review of the Q-test utility in diverse scenarios with 
a comparison of three different methods to estimate the heterogeneity between 
studies. Methods: Based on the global formulation of the Cochran’s Q-test, we 
proposed to analyse jointly the first error species and the second error species in 
different scenarios based on the number of studies included in each meta-analysis. 
The goal was to determine the reliability of the Q-test in extreme situations but also 
to give some benchmark for the reliability of this test. We use simulation methods 
to analyse the three different methods for calculating the between-study variance 
compared to the real value of heterogeneity. We also compared different arbitrary 
levels for model selection using these statistics in different scenarios. Results: The 
Cochran’s Q-test is too conservative with a large number of studies and concludes to 
the presence of heterogeneity whatever the situation is when the number of studies 
is higher than 18. In comparison, the different statistics have an average value con-
versely linked with the number of studies in case of non-heterogeneity: the higher 
the number of studies, the lower the statistics’ average values. ConClusions: The 
I2 and H2statistics can eventually enhance the use of Cochran’s Q-test by solving 
conservative issue associated with this test. The model selection can, eventually, be 
led by benchmark of these statistics jointly with the Cochran’s Q-test.
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objeCtives: Indirect comparisons are increasingly accepted to model the clini-
cal- and cost-effectiveness of treatments. The purpose of this study was to (i) 
assess the literature reporting on the use of novel statistical methods [simulated 
treatment comparison (STC), and matching-adjusted indirect comparison (MAIC)]; 
and (ii) assess technology appraisals (TAs) submitted to the National Institute of 
Health and Carel Excellence (NICE) to determine whether these techniques have 
been accepted by reimbursement authorities. Methods: Embase, Medline and 
the Cochrane Library were interrogated to identify publications reporting on the 
use of MAIC or STC. NICE TAs published from 2011-2014 which reported MAIC or 
STC analyses were identified and the critique by the appraisal group was summa-
rised. Results: Six publications reported on the use of MAIC in six indications. 
Results from these analyses concluded that MAIC offered several advantages over 
conventional meta-analysis methods that rely on aggregate data. Findings from the 
review of NICE TAs indicated that these novel statistical techniques have not been 
objeCtives: Patient preferences have implications for treatment decision mak-
ing, treatment adherence and follow-up care. This study aimed to highlight, using 
metastatic breast cancer (mBC) as an example, a method to elicit preferences and, of 
particular novelty, examine individual differences of those preferences. Methods: 
Using mixed methods, a qualitative study (n= 10) of patients with mBC informed 
the development of the preference survey (a cross-sectional Internet survey admin-
istered to women with mBC). Survey participants (N= 181) completed a conjoint 
exercise that included a series of choice questions. Each choice question included a 
pair of hypothetical treatments that were presented in terms of eight safety attrib-
utes, single attributes for effectiveness, dosing regimen, and quality of life. Survey 
choice data were analyzed using hierarchical Bayesian logistic regression models. 
Predicted values from this model were then analyzed to understand individual 
differences in patient preference. Results: Qualitative interviews identified the 
most relevant side effects to include in the choice task (e.g., alopecia, nausea/vomit-
ing, etc.) and reinforced the importance of quality of life when making treatment 
decisions. In the survey data, treatment effectiveness was most strongly associated 
with treatment preference, followed by alopecia, fatigue, neutropenia, and quality 
of life. Predicted values from the choice model enabled preference comparisons 
across treatment experience subgroups (e.g., 6+ rounds of chemotherapy vs. less). 
Preference strength for individual attributes, e.g., side effects was correlated with 
various demographic and health history variables, though only modest associations 
were detected (Pearson rs< 0.25). ConClusions: Understanding patient prefer-
ences provides opportunities for improved care and outcomes. Combining qualita-
tive and quantitative methods in this study allowed for specificity of preferences 
and generalizability (albeit limited). Patient preferences derived across the sample 
informed predicted values from the choice models that can also be used for compar-
ing preferences across subsamples and identifying factors that may be associated 
with certain preferences.
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objeCtives: Real-world (observational) data has the potential to address the limita-
tions of randomised controlled trials (RCTs) but presents its own challenges given 
the increased risk of bias. We compared the costs and quality-adjusted life years 
(QALYs) of patients following random vs preference-based allocation and assessed 
the performance of different methods to address these challenges. Methods: The 
REFLUX study was a pragmatic trial in patients with chronic reflux comparing lapa-
roscopic fundoplication (surgery) with medical management (MM) over 5 years of 
follow-up. The trial included randomised and non-randomised preference-based 
allocation. We compared the cost-effectiveness of surgery in the RCT vs preference 
cohorts as unadjusted raw differences, applying methods to handle biases from 
selection and confounding (regression adjustment, propensity score matching and 
instrument variable analysis) and explored the impact of receiving the preferred 
treatment on the results. Results: The preference surgery group accrued greater 
costs and QALYs than the randomised surgery group (£3,524 vs £2,852; 3.723 vs 
3.612 QALYs). The preference MM group had lower costs but slightly better QALYs 
than the randomised MM group (£861 vs £1,415; 3.541 vs 3.411 QALYs). The incre-
mental cost-effectiveness ratio (ICER) for the preference cohorts was similar to 
that obtained in the RCT using the different methods at around £8,000 per QALY 
gained (vs £7,149 in the RCT and £14,632 unadjusted raw differences). Receiving the 
preferred treatment was significantly associated with lower costs and better QALYs 
after adjusting for prognostic variables. ConClusions: Real-word data can be used 
in cost-effectiveness analysis to complement RCT evidence. However, more research 
is needed on how to choose the most appropriate method to adjust for selection 
bias and how to account for patient preferences when making recommendations 
on value for money.
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objeCtives: Mapping enables the prediction of health-state utility values via health 
outcome measures in trial data using algorithms linking those measures available 
to preference-based measures (PBMs). However, the unusual distributional features 
of PBMs mean that there is no consensus around the most appropriate statistical 
methodology for obtaining mapping algorithms. Existing studies have shown that 
structural equation modelling (SEM) developments open up a range of opportunities 
for effectively analysing PBMs. This study draws upon some of the methodological 
advances around SEMs from other fields in a case study. Progress towards develop-
ing a mapping algorithm for prediction of EQ-5D scores using a disease-specific 
measure, the Seattle Angina Questionnaire (SAQ), is discussed. Methods: EQ-5D 
and SAQ data were obtained from a completed RCT, the RITA-3 trial. Several psycho-
metric analysis approaches were considered to decide which subscales and items of 
the SAQ were likely to be relevant to the model. Several SEMs were specified and the 
first looked at the EQ-5D index values and SAQ subscales as continuous responses in 
a linear regression model. External information about the reliability of the disease-
specific measure was incorporated into this model. The subsequent models looked 
at the specification of outcomes at the item level with an ordinal logistic approach. 
Models were compared in terms of their ability to fit the observed data and their 
predictive performance. Results: Only three of the five subscales of the SAQ were 
